Ulo, Baby Girl N.

HRN: 20-78-84  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/12/2022
04/19/2022
IV
22MG
Q8
SEPCIS
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: